1/7 🧬Artificial intelligence could transform the clinical trial enterprise.
Trials remain the gold standard of evidence generation — yet they are slow, costly & operationally complex.
New review w/ @DLBhattMD in @EJCI_News examines how AI can reshape the trial lifecycle 🧵👇
🔗 https://t.co/A1CDL0sDUL
#ClinicalTrials #AIinMedicine
Clinical investigators look for statistical significance (a p-value less than 0.05) to determine if there is a difference between treatment groups. But that doesn’t necessarily mean that any such difference is clinically meaningful. Learn more: https://t.co/HxS1DAvWMu
Excited to share our multimedia publication at @NEJMEvidence explaining what minimal clinically important difference means in statistical research.
Thankful for the NEJM team and their mentorship! @ChanaSacks@JeffDrazen
https://t.co/f1kUlac3xa
Antibiotic duration for bacteremia is something most of us learned by habit, not by trial data. In the latest episode of Beyond Journal Club, a collaboration between @COREIMpodcast and NEJM Group, we walk through the BALANCE trial and use it as a lens to revisit how the factors of host, organism, and source should guide treatment; when is shorter really enough, and when isn’t it?
🎧 Listen to the full episode: https://t.co/lHuFPllzHf
📖 Further reading
Original Article by N. Daneman et al.: Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections https://t.co/3Z5oQ8yrg8
Such a fun episode to write & co-host as an editorial fellow @NEJM ! We talk everything bugs, bacteremia & antibiotic duration on @COREIMpodcast#antibiotics#stewardship
1/ 🚨7 days of #Antibiotics or more??! 🤔💊
BALANCE Trial walks us through the naunces of why ID might recommend x days of abx for #bacteremia
🎧: https://t.co/j6z3T8vaSi
2/ Special thanks to NEJM Group and everyone who made this possible! 🎬
Authors: @ShreyaTrivediMD , @gregorykatz , @ClementLeeMD , @NigamMinali
Experts: Dr. Matt Gwiazdon
Graphic: Dr. Jimin Hwang
Audio: Claire Yvon Ompoc Abatayo
Enjoyed presenting at #ESCCongress2025 in Madrid a pooled analysis of SCORED + SOLOIST-WHF:
✅Sotagliflozin improved HF outcomes + reduced MACE
📷Benefits consistent across ages, even >75 yrs
Important to study older adults in clinical trials
Thankful to mentor @DLBHATTMD
As we begin the new academic year with our medical trainees, we hope our list of top 10 high yield educational articles will bring knowledge and clinical pearls to everything #headache 🧠
Honored to work with the @HeadacheJournal to bring this together 💡
Essential readings in #headache medicine: Top 10 educational articles for trainees from 2022–2024
Guest editorial by Assistant Editors @NigamMinali & Nan Cheng MD!
Directly access the full manuscript using the link below:
https://t.co/4q5grjhiif
wow.
this means so much to me truly….french open champion🥹
i worked so hard for this moment and for it to have happened is insane. thank you God ❤️ and thank you everyone. this means the world…. I ‘m still in shock honestly can’t find the words but all I can say for now is just thank you and never give up on your dreams🫶🏾
In @AnnalsofIM, we find that patients in Medicare Advantage have a similar burden of many chronic medical conditions as those in Traditional Medicare
Yet these private insurance operated Advantage plans cost $83 billion more. Could over coding of diagnoses be causing this?
Insightful thread by lead author @AndrewOseran below. Thankful to our incredible mentor @rkwadhera
https://t.co/jNUipKL2WM
Join us for Headache School in Feb! 🧠
2/18: How Can TeleMedicine Help People with Migraine? | Sara Crystal, MD
2/25: Stroke and Migraine: What's the Link? | @NigamMinali
🕕 6:30 PM (MST)
💻 Free via Zoom
🔗 For more info & to join, visit our site! https://t.co/fwfwuQHMhy
1/Our new paper on the SCORED Trial, now published @TheLancetEndo
🧵 Sotagliflozin, a dual SGLT1/2 inhibitor, improved both myocardial infarction & stroke—a benefit in both not observed with other SGLT inhibitors.
https://t.co/F0QjQjIdTg
Special thanks to ⭐️mentor @DLBHATTMD
On this Valentine's Day, extend kindness to yourself & remember that every setback is a setup for a comeback. My latest is a reflection on overcoming professional rejection - hoping it resonates with anyone looking for a way to move forward. @doximity https://t.co/JHoTa7WqGn
What brain regions are involved in causing psychotic symptoms?
Take a moment away from the existential dread about the future of science, and join me in this summary of some incredibly cool stuff that could help patients!
1/n🧵
https://t.co/sBV6Lf12lR
New publication: CHANTER is an under-recognized syndrome of multifocal cerebral edema after opioid ingestion. It's important to recognize: diffusion restriction and edema are reversible and outcomes are promising!
Free copy: https://t.co/g5GBaUm49s
@DanHarrisonMD@BWHNeuroICU